[Pregnancy and COVID-19: drugs and vaccine guidelines in 2021]

Rev Med Suisse. 2022 Feb 2;18(767):165-168. doi: 10.53738/REVMED.2022.18.767.165.
[Article in French]

Abstract

During this global health crisis, COVID-19 unfortunately did not spare pregnant women, who are at greater risk of becoming infected, developing severe forms and having obstetric complications. In this article we will talk about the risks associated with COVID-19 during pregnancy and in particular the existing data on the drugs to be administered in the event of illness and how to avoid infection and its complications through vaccination.

Durant cette crise sanitaire mondiale, le Covid-19 n’a malheureusement pas épargné les femmes enceintes. Celles-ci sont plus à risque d’être infectées, de développer des formes sévères et d’avoir des complications obstétricales. Dans cet article, nous allons parler des risques liés au Covid-19 durant la grossesse et notamment des données existantes sur les médicaments à administrer en cas de maladie et comment éviter l’infection et ses complications grâce à la vaccination.

MeSH terms

  • COVID-19*
  • Female
  • Humans
  • Influenza Vaccines*
  • Pharmaceutical Preparations*
  • Pregnancy
  • Pregnancy Complications, Infectious* / prevention & control
  • SARS-CoV-2

Substances

  • Influenza Vaccines
  • Pharmaceutical Preparations